Psyence Biomedical Ltd. (PBM) quarterly balance sheet — complete assets, liabilities & equity history
Psyence Biomedical Ltd. (PBM) balance sheet — 5-year assets, liabilities & shareholders' equity history
| Metric | Q2'25 | Q2'24 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 7.63M | 2.24M | 1.13K | 162.52K | 181.39K | 288.6K | 1.62M | 540.93K | 652.54K | 797.2K | 973.22K | 9.91K |
| Cash & Short-Term Investments | 7.2M | 1.93M | 733 | 88.17K | 9.8K | 15.96K | 172.9K | 214.94K | 306.88K | 431.9K | 648.28K | 9.91K |
| Cash Only | 7.2M | 1.93M | 733 | 88.17K | 9.8K | 15.96K | 128.68K | 214.94K | 306.88K | 431.9K | 648.28K | 9.91K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 174.19K | 125.08K | 0 | 53.66K | 67.18K | 60.9K | 1.11M | 0 | 0 | 39.55K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -39.55K | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 29.61K | 71 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 324.94K | 0 |
| Total Non-Current Assets | 5.18M | 10.13K | 5 | 12.52M | 16.54M | 16.12M | 257.73M | 255.94M | 255.22M | 255.18M | 255.25M | 208.06K |
| Property, Plant & Equipment | 8.69K | 10.13K | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 5.17M | 0 | 0 | 12.52M | 16.54M | 16.12M | 257.73M | 255.92M | 255.12M | 255.01M | 255M | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.23K | 94.41K | 171.74K | 248.65K | 208.06K |
| Total Assets | 12.81M | 2.25M | 1.13K | 12.68M | 16.73M | 16.4M | 258.93M | 256.48M | 255.87M | 255.98M | 256.22M | 217.98K |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 468.46% | -82.23% | -100% | -95.06% | -93.46% | -93.59% | 1.06% | - | - | - | - | - |
| Total Current Liabilities | 943.07K | 3.51M | 12.1K | 16.18M | 15.26M | 14.88M | 14.27M | 187.04K | 213.7K | 142.67K | 68.7K | 272.47K |
| Accounts Payable | 0 | 805.61K | 562 | 0 | 0 | 1.63M | 2.19K | 0 | 0 | 36.89K | 0 | 0 |
| Days Payables Outstanding | - | 36.2K | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 2.5M | 10.45K | 1.61M | 1.18M | 685K | 0 | 0 | 0 | 0 | 0 | 90.09K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 943.07K | 190.11K | 969 | 14.57M | 14.09M | 12.57M | 14.27M | 187.04K | 213.7K | 105.79K | 68.7K | 182.38K |
| Current Ratio | 8.09x | 0.64x | 0.09x | 0.01x | 0.01x | 0.02x | 0.11x | 2.89x | 3.05x | 5.59x | 14.17x | 0.04x |
| Quick Ratio | 8.09x | 0.64x | 0.09x | 0.01x | 0.01x | 0.02x | 0.11x | 2.89x | 3.05x | 5.86x | 14.17x | 0.04x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.88M | 14.01M | 16.24M | 19.51M | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.88M | 14.01M | 16.24M | 19.51M | 0 |
| Total Liabilities | 943.07K | 3.51M | 12.1K | 16.18M | 15.26M | 14.88M | 14.27M | 14.07M | 14.23M | 16.38M | 19.58M | 272.47K |
| Total Debt | 0 | 2.5M | 10.45K | 1.61M | 1.18M | 685K | 0 | 0 | 0 | 0 | 0 | 90.09K |
| Net Debt | -7.2M | 568.34K | 9.71K | 1.52M | 1.17M | 669.04K | -128.68K | -214.94K | -306.88K | -431.9K | -648.28K | 80.18K |
| Debt / Equity | - | - | - | - | 0.81x | 0.45x | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | -0.04x | -0.20x | -0.12x | -0.12x | -0.06x | - |
| Interest Coverage | -272.61x | 39.08x | -55.12x | -31.82x | - | - | - | - | - | - | - | - |
| Total Equity | 11.87M | -1.26M | -10.97K | -3.5M | 1.46M | 1.52M | 244.66M | 242.41M | 241.64M | 239.6M | 236.65M | -54.49K |
| Equity Growth % | 1045.5% | 64.11% | -100% | -101.44% | -99.4% | -99.36% | 3.39% | - | - | - | - | - |
| Book Value per Share | 8.01 | -4.54 | -0.00 | -0.45 | 0.18 | 0.13 | 7.49 | 8.50 | 8.47 | 8.40 | 7.24 | -0.00 |
| Total Shareholders' Equity | 11.87M | -1.26M | -10.97K | -3.5M | 1.46M | 1.52M | 244.66M | 242.41M | 241.64M | 239.6M | 236.65M | -54.49K |
| Common Stock | 68.88M | 52.94M | 46.13K | 12.57M | 16.61M | 16.18M | 258.55M | 255.92M | 255M | 255M | 255M | 661 |
| Retained Earnings | -58.44M | -54.5M | -57.46K | -16.07M | -15.15M | -14.65M | -13.9M | -13.51M | -13.36M | -15.4M | -18.36M | -79.49K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.42M | 260.02K | 361 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |